MedTrace Logo

Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:

NCT02872727 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2026-05-14

No results posted yet for this study

Summary

The object of this new project is to proceed with investigations with the employees of the cohort for the first study so as to obtain a remote evolution (5 years) of their respiratory function while measuring their nanoparticle exposure. This will enable us to assess the possible link between exposure and respiratory function evolution in the employees

Conditions

  • Air France Company's Employees Working in the Marseilles and Paris Airports (Flightline and Administrative Employees)

Interventions

OTHER

Respiratoy health, biological investigations

Once the subjects have agreed to participate, self-surveys on their lifestyle habits will be filled and EACand urine samplings will be taken during one same consultation, in addition to exhaled CO and No measurements. This consultation will also include a spirometry test. The employees' workstation data (and their evolution since the first study) will be collected. Therefore, the volunteers' participation is limited to one single visit including non-invasive examinations and self-surveys.

Sponsors & Collaborators

  • Aix Marseille Université

    collaborator OTHER

  • LBM- Nanosecurity platform - CEA Grenoble

    collaborator UNKNOWN

  • LR2N - Nanosecurity platform - CEA Grenoble

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • NICOLAS MOLINARI · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2020-12-13
Completion
2021-06-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02872727 on ClinicalTrials.gov